ContraVir

YTD

ALL

Why Robinhood?

You can watch ContraVir and buy or sell other stocks, ETFs, and their options commission-free!

About CTRV

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate, Rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease.

CEO

John Patrick Brancaccio, CPA

CEOJohn Patrick Brancaccio, CPA

Employees

—

Employees—

Headquarters

Morristown, New Jersey

HeadquartersMorristown, New Jersey

Founded

2013

Founded2013

Employees

—

Employees—

CTRV Key Statistics

Market cap

3.47M

Market cap3.47M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

2.82M

Average volume2.82M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$68.00

52 Week high$68.00

52 Week low

$0.25

52 Week low$0.25